Selective serotonin reuptake inhibitors and torsade de pointes: new concepts and new directions derived from a systematic review of case reports

OBJECTIVE: In the light of the recent United States Food and Drug Administration (FDA) warning to clinicians on using previously approved doses of citalopram because of the purported higher risk of torsade de pointes (TdP), we pursued the broader question: are selective serotonin reuptake inhibitor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kogut, Christopher, Crouse, Ericka Breden, Vieweg, W. Victor R., Hasnain, Mehrul, Baranchuk, Adrian, Digby, Geneviève C., Koneru, Jayanthi N., Fernandez, Antony, Deshmukh, Anand, Hancox, Jules C., Pandurangi, Ananda K.
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2013
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4125314/
https://ncbi.nlm.nih.gov/pubmed/25114780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042098613492366
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados